6ER-005 Comprehensive programme for prevention and control of infections related to health care and appropriate use of antimicrobials: one more step

Autor: A Henares López, I Márquez Gómez, I Muñoz Castillo, R Asensi Diez, LB Valiente de Santis, JM Reguera Iglesias, JM Salas Pérez, L Yunquera Romero

Publikováno v: Eur J Hosp Pharm

Background Inappropriate prescription of antimicrobials has a significant epidemiological impact, since it favours the selection of strains of resistant microorganisms. Purpose Evaluate the changes in antimicrobials or route of administration by the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a12e96fc1e0d5b28892f84200cfe1a1
https://doi.org/10.1136/ejhpharm-2018-eahpconf.498

Gastroprotective role of a flavonoid-rich subfraction from Fridericia chica (Bonpl.) L. G. Lohmann: a medicinal plant used in the Amazon region.

Autor: Miorando, Daniela, Steffler, Amanda M., Vecchia, Cristian A. Dalla, Simomura, Viviane L., Veloso, Jaqueline J., Buzatto, Maike V., Nunes, Ruan K. S., Somensi, Lincon B., Gutiérrez, Max V., Melim, Lorane I. S. H., Pontes, Franco M. M., Silva, Luisa M., Veselinova, Anzhela, González-Sánchez, Lola, Jambrina, Pablo G., Junior, Walter A. Roman

Publikováno v: Inflammopharmacology; Oct2024, Vol. 32 Issue 5, p3499-3519, 21p

6ER-005 Comprehensive programme for prevention and control of infections related to health care and appropriate use of antimicrobials: one more step

Autor: Diez, R Asensi, Pérez, JM Salas, Léópez, A Henares, Iglesias, JM Reguera, Santis, LB Valiente de, Géóáómez, I Méóárquez, Romero, L Yunquera, Castillo, I Muéóáóñoz

Publikováno v: European Journal of Hospital Pharmacy : Science and Practice; 2018, Vol. 25 Issue: Supplement 1 pA231-A232, 2p

Mural Endocarditis: The GAMES Registry Series and Review of the Literature.

Autor: Gutiérrez-Villanueva, Andrea¹ (AUTHOR), Muñoz, Patricia^2,3,4,5 (AUTHOR), Delgado-Montero, Antonia⁶ (AUTHOR), Olmedo-Samperio, María^2,3,4,5 (AUTHOR), de Alarcón, Arístides⁷ (AUTHOR), Gutiérrez-Carretero, Encarnación⁸ (AUTHOR), Zarauza, Jesús⁹ (AUTHOR), García i Pares, Delia^10,11 (AUTHOR), Goenaga, Miguel Ángel¹² (AUTHOR), Ojeda-Burgos, Guillermo¹³ (AUTHOR), Goikoetxea-Agirre, Ane Josune¹⁴ (AUTHOR), Reguera-Iglesias, José Mª¹⁵ (AUTHOR), Ramos, Antonio¹⁶ (AUTHOR), Fernández-Cruz, Ana¹⁶ (AUTHOR) anafcruz999@gmail.com, Spanish Collaboration on Endocarditis—Grupo de Apoyo al Manejo de la Endocarditis infecciosa en España (GAMES) (AUTHOR), Fernández-Sánchez, Fernando (AUTHOR), García de Lomas, José Mª (AUTHOR), Rosas, Gabriel (AUTHOR), de la Torre Lima, Javier (AUTHOR), Bereciartua, Elena (AUTHOR)

Publikováno v: Infectious Diseases & Therapy. Dec2021, Vol. 10 Issue 4, p2749-2764. 16p.

Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study.

Autor: Zhou H; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.; Department of Hospital Infection Control, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China., Buetti N; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.; Infection Antimicrobials Modeling Evolution (IAME) U 1137, INSERM, Université Paris-Cité, Paris, France., Pérez-Galera S; Unidad Clínica de Medicina Interna, Hospital Universitario Virgen Macarena, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain., Bravo-Ferrer J; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain., Gutiérrez-Gutiérrez B; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Paniagua-García M; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Seville, Spain., Feifel J; Institute of Statistics, Ulm University, Ulm, Germany., Sauser J; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Kostyanev T; Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium.; National Food Institute, Technical University of Denmark, Lyngby, Denmark., Canton R; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Tan LK; Research and Development, GlaxoSmithKline, London, UK., Basoulis D; First Department of Internal Medicine, Laiko General Hospital, Athens, Greece., Pintado V; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Roilides E; Faculty of Health Sciences, Hippokration General Hospital of Thessaloniki, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Dragovac G; Faculty of Medicine and Institute of Public Health of Vojvodina, University of Novi Sad, Novi Sad, Serbia., Torre-Cisneros J; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Departamento de Ciencias Médicas y Quirúrgicas, Servicio de Enfermedades Infecciosas Hospital Universitario Reina Sofía/Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Universidad de Córdoba, Córdoba, Spain., Mediç D; Faculty of Medicine and Institute of Public Health of Vojvodina, University of Novi Sad, Novi Sad, Serbia., Akova M; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Sihhiye, Ankara, Turkey., Goossens H; Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium., Bonten M; Julius Center for Health Sciences and Primary Care and University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Harbarth S; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Rodriguez-Baño J; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Departamento de Medicina, Universidad de Sevilla, Seville, Spain.; Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Seville, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., De Kraker MEA; Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Sep 03; Vol. 79 (9), pp. 2132-2141.